Category: Media coverage

CHILD Cohort Study profiled in Wave magazine

Ilsa Buchholz is one of the almost 3,500 kids participating in the CHILD Cohort Study. Hear about what being a part of CHILD means to Ilsa and her parents, what tests Ilsa undergoes every few years during her clinical visit,

CHILD microbiome paper is CMAJ‘s top article for 2018 media coverage

A study led by AllerGen investigator Dr. Anita Kozyrskyj and published in the Canadian Medical Association Journal (CMAJ) in September 2018, is the journal’s top article for 2018 in terms of media coverage. The study used data from CHILD Study

Chatelaine shares AllerGen, CHILD food allergy research results

A new article in Chatelaine magazine highlights the latest developments in the fight against food allergies, providing national exposure for AllerGen investigators, trainees, partner organizations and AllerGen-supported food allergy research. “How Close Are We to a Cure for Food Allergies?”

Interview videos highlight CHILD research

A January 2018 video interview with AllerGen investigator Dr. Meghan Azad, entitled “Meghan Azad on Studying Chronic Diseases in Children” and produced by the Human Capital and Economic Opportunity (HCEO) Global Working Group, explores Dr. Azad’s work on the developmental

“Direct breastfeeding seems most protective against asthma development”

An article in MD Magazine will help physicians use CHILD Study research on breastfeeding to provide better patient care. The article highlights the finding, published in Journal of Pediatrics in November 2017, that direct breastfeeding in the first three months

Anaphylaxis study finds reactions to food common among children despite adult supervision

“I think we have a false sense of security that as long as our food-allergic child is at home under the supervision of an adult we know, the child will be fine; but apparently, that isn’t the case,” says AllerGen

AllerGen researchers profiled for CIHR 150

In recognition of Canada’s 150th anniversary, the Canadian Institutes for Health Research (CIHR) is “celebrating health research” by sharing the stories of Canadian researchers and patients. The CIHR website now profiles the work of numerous AllerGen researchers and HQP. Click

CIC-tested biologic poised to become a “game-changing, blockbuster” asthma drug

In 2014, AllerGen’s Clinical Investigator Collaborative (CIC) conducted an early Phase II clinical trial on the injectable biologic drug tezepelumab, developed by MedImmune (the biologics arm of AstraZeneca) and Amgen, and first identified the drug’s significant therapeutic potential. “Now, it’s

AllerGen researcher featured in CIHR breastfeeding panel

On August 2, 2017, AllerGen investigator Dr. Meghan Azad (University of Manitoba) participated in a panel discussion organized by the CIHR’s Institute of Human Development, Child & Youth Health (IHDCYH) on breastfeeding and children’s health. In the event, Dr. Azad

New microbiome book highlights AllerGen research

A new book, describing the “seed-and-feed” process by which a baby’s gut microbiome is established, features AllerGen investigator Dr. Anita Kozyrskyj and her research using CHILD Study data. Written for the general public, Your Baby’s Microbiome: The Critical Role of

CHILD Study in The Economist

The Economist magazine highlights the CHILD Study in its February 25, 2017, issue. The article, “Four good bugs,” profiles research led by AllerGen investigator Dr. Brett Finlay of The University of British Columbia, which looks at the relationship between gut

Dr. Malcolm Sears, Dunedin Study featured in documentary series

AllerGen Research Leader Dr. Malcolm Sears is featured in a 2016 documentary series chronicling the lives of 1,037 people born in Dunedin, New Zealand during 1972-73. The series, Predict My Future: The Science of Us, reveals the fascinating findings from

Top